Literature DB >> 32127688

CYP27B1 as an instrument gene to investigate the causal relationship between vitamin D deficiency and obesity: a family-based study.

Songcheng Yu1, Yinhua Feng1, Chenling Qu2, Wenqian Huo1, Zhenxing Mao1, Chongjian Wang1, Wenjie Li1, Xing Li3.   

Abstract

OBJECTIVES: Vitamin D deficiency was associated with obesity. However, the causal relationship remains controversial. We hypothesized that there would be family-based associations in both vitamin D deficient families and obese families for the SNPs associated with vitamin D deficiency, if vitamin D deficiency was a causal factor of obesity. We aimed to investigate the family-based association of SNPs in CYP27B1 with both vitamin D deficiency and obesity.
METHODS: Four hundred and nineteen pedigrees containing 1505 rural individuals aged from 18 to 79 years in Henan Province of China were included in this study. Family-based associations of rs10877012 and rs4646536 in CYP27B1 with vitamin D deficiency and obesity were investigated. Serum 25(OH)D3 concentration <20 μg/L was defined as vitamin D deficiency. BMI ≥ 28 kg/m2 was applied for obesity definition. Taqman assays were applied for SNP genotyping. Family-based associations were investigated with FBAT software.
RESULTS: It was shown that vitamin D deficiency was a risk factor of obesity (adjusted OR: 1.332, 95% CI: 1.042-1.703, P = 0.022). Furthermore, there were family-based associations for allele T of rs10877012 and allele T of rs4646536 in both vitamin D deficient families and obese families (P < 0.05). Both rs10877012 and rs4646536 were associated with serum 25(OH)D3 levels between siblings (P < 0.05), but not BMI (P > 0.05). In addition, there is linkage disequilibrium between rs10877012 and rs4646536 (D' = 1.0, r2 = 0.992).
CONCLUSION: Vitamin D deficiency may be a causal factor of obesity. Maintaining sufficient vitamin D is beneficial to obesity prevention.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32127688     DOI: 10.1038/s41430-020-0594-7

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  6 in total

Review 1.  Obesity and vitamin D deficiency: a systematic review and meta-analysis.

Authors:  M Pereira-Santos; P R F Costa; A M O Assis; C A S T Santos; D B Santos
Journal:  Obes Rev       Date:  2015-02-17       Impact factor: 9.213

Review 2.  Genetic and epigenetic factors influencing vitamin D status.

Authors:  Afsane Bahrami; Hamid Reza Sadeghnia; Seyed-Amir Tabatabaeizadeh; Hamidreza Bahrami-Taghanaki; Negin Behboodi; Habibollah Esmaeili; Gordon A Ferns; Majid Ghayour Mobarhan; Amir Avan
Journal:  J Cell Physiol       Date:  2017-11-28       Impact factor: 6.384

Review 3.  Vitamin D status and the metabolic syndrome.

Authors:  Ligia A Martini; Richard J Wood
Journal:  Nutr Rev       Date:  2006-11       Impact factor: 7.110

4.  Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases--report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults.

Authors:  Bei-Fan Zhou
Journal:  Biomed Environ Sci       Date:  2002-09       Impact factor: 3.118

Review 5.  Vitamin D and adipogenesis: new molecular insights.

Authors:  Richard J Wood
Journal:  Nutr Rev       Date:  2008-01       Impact factor: 7.110

6.  Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes.

Authors:  Rebecca Bailey; Jason D Cooper; Lauren Zeitels; Deborah J Smyth; Jennie H M Yang; Neil M Walker; Elina Hyppönen; David B Dunger; Elizabeth Ramos-Lopez; Klaus Badenhoop; Sergey Nejentsev; John A Todd
Journal:  Diabetes       Date:  2007-07-02       Impact factor: 9.461

  6 in total
  2 in total

1.  Polymorphisms CYP2R1 rs10766197 and CYP27B1 rs10877012 in Multiple Sclerosis: A Case-Control Study.

Authors:  A Martinez-Hernandez; E E Perez-Guerrero; M A Macias-Islas; C A Nava-Valdivia; A Villagomez-Vega; B Contreras-Haro; Y E Garcia-Ortega; Y Esparza-Guerrero; S G Gallardo-Moya; J I Gamez-Nava; L Gonzalez-Lopez; E Oliva-Flores; N A Rodriguez-Jimenez; F Cortes-Enriquez; A M Saldaña-Cruz
Journal:  J Immunol Res       Date:  2021-12-23       Impact factor: 4.818

2.  Vitamin D metabolism pathway polymorphisms are associated with efficacy and safety in patients under anti-PD-1 inhibitor therapy.

Authors:  Jianquan Luo; Huiqing Chen; Fang Ma; Chenlin Xiao; Bao Sun; Yiping Liu; Haoneng Tang; Yue Yang; Wenhui Liu; Zhiying Luo
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.